NXTC
NextCure, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website nextcure.com
- Employees(FY) 99
- ISIN US65343E1082
Performance
-2.91%
1W
+1.83%
1M
+14.38%
3M
+42.74%
6M
+46.49%
YTD
-4.57%
1Y
Profile
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Technical Analysis of NXTC 2024-05-10
Overview:
In analyzing the technical indicators for NXTC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been consistently above the c...
Recent News & Updates
- 2024-05-02 09:57
NXTC Stock Earnings: NextCure Misses EPS for Q1 2024(Investorplace)
- 2024-05-02 04:05
- 2024-04-24 04:05
- 2024-04-07 19:00
- 2024-04-03 19:05
- 2024-04-01 19:00
- 2024-03-22 18:00
- 2024-03-21 10:54
NXTC Stock Earnings: NextCure Beats EPS for Q4 2023(Investorplace)
- 2024-03-20 23:22
NextCure to lay off 37% of staff, dial back research plans(Yahoo Finance)
- 2024-03-20 20:55
- 2024-03-04 19:05
- 2024-01-18 03:05
- 2023-12-24 20:55
- 2023-12-20 18:05
- 2023-12-14 22:23
NextCure (NXTC) Down on Shelving Plans to Develop Candidate(Yahoo Finance)
- 2023-12-13 20:14
- 2023-12-13 17:45
NextCure Provides Year-End Clinical Pipeline Updates(Globenewswire)
- 2023-11-19 18:00
- 2023-11-15 03:05
- 2023-11-06 23:00
- 2023-11-02 06:07
NextCure Inc (NXTC) Reports Q3 2023 Financial Results(Yahoo Finance)
- 2023-11-02 04:05
- 2023-10-16 20:05
- 2023-09-26 04:05
- 2023-09-11 20:05
- 2023-09-07 04:05
- 2023-09-05 04:05
- 2023-08-30 19:00
- 2023-08-03 04:05
- 2023-06-21 04:05
Page 1 of 4
previousnext